EUVIMEDEUVIMED entdecken
Crossref

Evaluating the Long-Term Outcomes of Medical and Surgical Treatments in Fibrostenotic Crohn’s Disease Patients Treated with Anti-TNF/Biologic Therapy

Çağatay Ak, Süleyman Sayar, Resul Kahraman, Kamil Özdil

Experimed · 2022

DOI: 10.26650/experimed.1183920 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Experimed, 2022. Verfasst von Çağatay Ak und 3 weiteren Autor:innen.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Zitieren

APA

Ak, Ç., Sayar, S., Kahraman, R., & Özdil, K. (2022). Evaluating the Long-Term Outcomes of Medical and Surgical Treatments in Fibrostenotic Crohn’s Disease Patients Treated with Anti-TNF/Biologic Therapy. Experimed. https://doi.org/10.26650/experimed.1183920

Vancouver

Ak Ç, Sayar S, Kahraman R, Özdil K. Evaluating the Long-Term Outcomes of Medical and Surgical Treatments in Fibrostenotic Crohn’s Disease Patients Treated with Anti-TNF/Biologic Therapy. Experimed. 2022. doi:10.26650/experimed.1183920

BibTeX
@article{Ak2022,
  author = {Ak, Çağatay and Sayar, Süleyman and Kahraman, Resul and Özdil, Kamil},
  title = {Evaluating the Long-Term Outcomes of Medical and Surgical Treatments in Fibrostenotic Crohn’s Disease Patients Treated with Anti-TNF/Biologic Therapy},
  journal = {Experimed},
  year = {2022},
  doi = {10.26650/experimed.1183920}
}
Kostenlos starten →